Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced today the appointment of Dr. Hacene Boudries as Director of Technology, marking the latest in a series of high-level industry experts added to Implant Sciences' management team.
Dr. Boudries was most recently with Morpho Detection Inc. where he was Director, Research & Technology, Chemical/Biological Detection & Chemical Sensing at Morpho Detection's Advanced Technology Programs. At Morpho he took products from proof of concept and R&D prototype to commercialization. Previously, Dr. Boudries was Research and Development Manager in charge of Chemical/Biological Detection at General Electric Security. He has worked at the Massachusetts Institute of Technology's Department of Chemical Engineering as a Research Engineer and served as Principal Scientist at Aerodyne Research, Inc. Dr. Boudries holds a Master of Science and a PhD in Physical Chemistry from the University of Paris VII in Paris, France.
"Dr. Boudries will be a key contributor to our strategy of introducing next generation technology to the security market. His strong record of success with trace and advanced chemical detection coupled with extensive experience with the TSA and other government certification initiatives will make him an excellent addition to our technical team," stated Implant Sciences' Vice President of Technology, Todd Silvestri.
"We continue to attract some of the top talent in our industry. Our success in drawing experienced personnel from larger companies in the homeland security market gives us a strong framework for growth. The team we have assembled inspires confidence in our ability to strategically advance in our industry," added Implant Sciences' President and CEO, Glenn D. Bolduc.
Source: Implant Sciences Corp.
Date: Oct 9, 2012